26 C
Vientiane
Tuesday, October 7, 2025
spot_img
Home Blog Page 140

Nature’s Miracle Holding Inc. (“NMHI”), Datavault AI (“DVLT”) and Harrison Global Holdings Inc. (“BLMZ) Join Forces to Launch the X Club for the Global XRP Community

ONTARIO, Calif., Sept. 22, 2025 /PRNewswire/ — Nature’s Miracle Holding Inc. (OTCQB:NMHI) along with Datavault AI Inc.(Nasdaq: DVLT) and Harrison Global Holdings Inc.(Nasdaq: BLMZ) are pleased to announce the launch of X Club for the global XRP community at the XRP Seoul Global Conference on September 21, 2025.

The mission of the X Club is to promote the adoption of XRP Digital Treasury Strategy by public companies listed around the world. In addition, the X Club will work with existing stakeholders in the XRP community to foster the ecosystem for the application of XRP in cross border payment, tokenization and investments. The X Club will be open to all stakeholder in the XRP community.

The three main focuses of the X Club will be as follows:

  1. Technological and application research: Using the native XRPL technology for the optimization of the related adoption of XRP across industries and applications;
  2. Global Brand Awareness and Brand Recognition: Promote the XRP brand recognition through global events and conference;
  3. Regulatory and Standard: Work with Ripple and other regulatory bodies around the world to for the relevant industry standard for compliance.

The three public companies agree to the following immediate tasks:

  1. Setting up working group to study the cross boarder payment, tokenization and XRP digital treasury opportunities;
  2. Public white paper on the best practices in those above-mentioned areas;
  3. Establish partnerships and networks with all stakeholders in the XRP community.

Tie, “James”, Li, Chairman of Nature’s Miracle Holding Inc., comments, “We are excited to work with Datavault AI and Harrison Global to launch the X Club in Korea, which is one of the most important markets for XRP. This is an exciting time for the adoption of XRP in many areas around the world and the X Club will greatly facilitate the discussion surrounding XRP. We are looking forward to having more partners joining us in this journey.”

Nate Bradley, CEO of Datavault AI, comments, “The launch of X Club will enable us to streamline our RWA process by using XRPL technology for our Element Exchange. Very excited to work with Nature’s Miracle Holding and Harrison Global Holding on this endeavor.”

Ryoshin Nakade, CO-CEO of Harrison Global Holding Inc., comments, “We are truly honored to announce the establishment of the ‘X Club’ at the XRP Seoul Global Conference. X Club serves as an international collaborative platform to promote the implementation of cross-border payments, tokenization, and digital treasury strategies utilizing XRP. As a founding member, Harrison Global is committed to actively contributing to this initiative. We regard the expansion of the XRP ecosystem through IPOs and capital increases by publicly listed companies as a key strategic priority.”

About Nature’s Miracle Holding Inc.
Nature’s Miracle Holding Inc. (OTCQB: NMHI) (www.Nature-Miracle.com) is a growing agriculture technology company providing products and services to growers in the Controlled Environment Agriculture (“CEA”) industry in the U.S.  The Company also engages in electric vehicle distribution and bitcoin mining. The Company has recently announced a number of initiatives to become one of the first public companies utilizing XRP digital treasury program and the related application of XRP technologies. The Company’s Common Stock trades on the OTCQB market (“OTCQB”) under the symbol “NMHI”.

About Datavault AI Inc.
Datavault AI Inc. (Nasdaq: DVLT), (https://datavaultsite.com/), a data sciences technology company, owns and operates data management platforms by supercomputing capabilities in the North America, Asia Pacific, Europe, and internationally. The company offers data technology and software solutions that enable customers to thrive in the evolving landscape of data ownership, privacy, and security through high performance computing (HPC) infrastructure and proprietary software. In addition, it also provides registration, data analytics, and lead management services for live events, offering cutting-edge solutions, and unparalleled customer support to clients in the trade, association, corporate, and government event markets. The company was formerly known as WiSA Technologies, Inc. and changed its name to Datavault AI Inc. in February 2025. Datavault AI Inc. was incorporated in 2010 and is headquartered in Beaverton, Oregon.

About Harrison Global Holdings Inc.
Harrison Global Holdings Inc. (Nasdaq: BLMZ) (https://www.bloomz-inc.com/) operates as an audio producing and voice actor managing company in Japan. It offers audio production services; and VTuber, a virtual character that enables streamers to provide their voice to stream real-time videos of human facial expressions and gestures. The company also provides voice acting educational services to Japanese youths. The company was formerly known as BloomZ Inc. and changed its name to Harrison Global Holdings Inc

Forward-Looking Statements
The information in this press release includes “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include, but are not limited to, statements regarding expectations, hopes, beliefs, intentions or strategies regarding the future. In addition, any statements that refer to projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. The words “anticipate,” “believe,” “contemplate,” “continue,” “could,” “estimate,” “expect,” “forecast,” “intends,” “may,” “will,” “might,” “plan,” “possible,” “potential,” “predict,” “project,” “should,” “would” and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. Forward-looking statements in this press release may include, for example: the intended use of proceeds from the offering; successful launch and implementation of Nature’s Miracle’s joint projects with manufacturers and other supply chain participants of steel, rubber and other materials; changes in Nature’s Miracle’s strategy, future operations, financial position, estimated revenues and losses, projected costs, prospects and plans; Nature’s Miracle’s ability to develop and launch new products and services; Nature’s Miracle’s ability to successfully and efficiently integrate future expansion plans and opportunities; Nature’s Miracle’s ability to grow its business in a cost-effective manner; Nature’s Miracle’s product development timeline and estimated research and development costs; the implementation, market acceptance and success of Nature’s Miracle’s business model; developments and projections relating to Nature’s Miracle’s competitors and industry; and Nature’s Miracle’s approach and goals with respect to technology.

These forward-looking statements are based on information available as of the date of this press release, and current expectations, forecasts and assumptions, and involve a number of judgments, risks and uncertainties. Accordingly, forward-looking statements should not be relied upon as representing views as of any subsequent date, and no obligation is undertaken to update forward-looking statements to reflect events or circumstances after the date they were made, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws. As a result of a number of known and unknown risks and uncertainties, actual results or performance may be materially different from those expressed or implied by these forward-looking statements. Some factors that could cause actual results to differ include: the ability to maintain the quotation of the Company’s shares on the OTC; changes in applicable laws or regulations; the ability to implement business plans, forecasts, and other expectations, and identify and realize additional opportunities; the risk of downturns and the possibility of rapid change in the highly competitive industry in which Nature’s Miracle’s operates; the risk that Nature’s Miracle’s and its current and future collaborators are unable to successfully develop and commercialize Nature’s Miracle’s products or services, or experience significant delays in doing so; the risk that the Company may never achieve or sustain profitability; the risk that the Company will need to raise additional capital to execute its business plan, which may not be available on acceptable terms or at all; the risk that the Company experiences difficulties in managing its growth and expanding operations; the risk that third-party suppliers and manufacturers are not able to fully and timely meet their obligations; the risk that Nature’s Miracle’s is unable to secure or protect its intellectual property; the possibility that Nature’s Miracle’s may be adversely affected by other economic, business, and/or competitive factors; and other risks and uncertainties described in Nature’s Miracle’s filings from time to time with the SEC.

 

vivo Shines with Dual Honors: No.34 on BrandZ Top 100 and “2025 Kantar BrandZ Inspirational Star of Innovation” Award

SHANGHAI, Sept. 22, 2025 /PRNewswire/ — At the 2025 Kantar BrandZ China Gala, themed “Neo Intelligence Brand Power” and held in Shanghai, vivo ranked 34th on the BrandZ Top 100 list for the second year in a row, with a brand value of USD 5.989 billion, marking steady growth from the previous year. Thanks to its continuous innovation in areas such as 5G communications, artificial intelligence, and mobile imaging, vivo also received the “2025 Kantar BrandZ Inspirational Star of Innovation” Award, once again highlighting its industry-leading innovation capabilities.


The year 2025 marks the 30th anniversary of vivo’s founding. Over the past three decades, vivo has consistently adhered to a user-oriented philosophy, placing human concerns at the forefront. By leveraging a dual-driven R&D strategy of “in-house development” and “collaborative research,” and with a long-term commitment, vivo has successfully navigated multiple industry cycles and continuously delivered products and services that exceed user expectations.

In terms of technology layout, vivo has introduced its self-developed technology brand “BlueTech,” centered around four long-term strategic tracks: design, imaging, system, and performance. This includes a range of core innovations such as BlueChip, BlueOcean, BlueLM, BlueOS, and BlueImage. These technologies not only establish vivo’s differentiated competitive edge but also serve as a solid foundation for its user-centric innovation.

These technological strengths have quickly translated into outstanding product performance. With the ongoing boom in the concert market, vivo’s imaging flagship model, the X200 Ultra, has been hailed by users as the “concert essential” due to its exceptional telephoto and low-light capabilities. This product not only reflects the successful implementation of “BlueTech” and long-track R&D but also stands as a benchmark for vivo in exceeding users’ highest expectations. It is expected that in October this year, vivo will launch the X300 series, redefining the industry standard for flagship imaging experiences and giving a strong boost to its continued breakthroughs in the premium market.

Recently, vivo released its mixed reality headset, the vivo Vision Explorer Edition, bringing mixed reality technology from the lab into everyday application scenarios and opening a door to a new digital world for users. The launch of the vivo Vision positions vivo as the first domestic technology company to build a complete mixed reality experience based on the underlying capabilities of a hardware manufacturer, as well as the first in China to simultaneously develop both smartphones and MR (mixed reality) devices—thus initially achieving an “ecosystem closed loop” from content creation to terminal experience.

In the global market, vivo is guided by the core philosophy of “More Local, More Global,” committed to deeply integrating globally unified business logic with localized execution strategies. It drives product innovation and service upgrades through user insights. Its success in markets such as Southeast Asia is built on accurately responding to regional needs and implementing solutions swiftly. Meanwhile, vivo’ s comprehensive retail and service network provides localized, highly efficient services, further solidifying the brand’s recognized advantage in delivering “meaningful difference.”

Looking ahead, vivo will continue to uphold its original aspiration of “Technology Illuminating a Better Future,” remain user-centered, and drive progress with innovation. On the global stage, vivo will keep showcasing the wisdom and strength of Chinese brands.

 

Locksley Continues to Strengthen its Position in Paving Pathway to 100% Made in America

Company Reports Exceptional Initial Metallurgical Results for Its US Mojave Project

SAN BERNARDINO, Calif, Sept. 22, 2025 /PRNewswire/ — Locksley Resources Ltd. (ASX: LKY; OTCQB: LKYRF) announced it has achieved significant results from initial metallurgical testwork completed by the company on samples collected from the Desert Antimony Mine (DAM) Prospect. These results validate that the Mojave Project can deliver feedstock required to underpin a domestic mine-to-market antimony supply chain. Recovery rates of the level indicated in the initial testing confirm Locksley’s pathway to 100% Made in America Antimony, which is directly aligned with U.S. government priorities for onshore critical mineral supply security.

For the six samples assessed, antimony grades ranged from a low of 27.5% to a high of 39.1%. Recovery rates ranged from 82.9% to 85.9% among the six samples. Additional details are available here: https://cdn-api.markitdigital.com/apiman-gateway/ASX/asx-research/1.0/file/2924-02996029-6A1284968&v=c2533a54e2514fb77a8f93f84db686e1125273e9

“This is an excellent milestone to have achieved for the Mojave Project,” said Julian Woodcock, Technical Director of Locksley Resources. “It demonstrates that conventional flotation technology is suitable to produce a stibnite concentrate from the Desert Antimony Mine Prospect. What is also remarkable is the success of the testwork on surface samples, which have been susceptible to oxidation. I am extremely encouraged by the results and optimistic that with further testwork we will be able to improve on this already high-quality first-pass outcome. This activity continues to rapidly advance our strategy to provide onshore supply of antimony to the U.S. market.”

Concentrate from these tests was sent to Rice University to commence with Deep Eutectic Solvent Extraction testwork using Rice University’s Deep Solv™ methodology, in conjunction with the recently announced partnership by Locksley and Rice.

Locksley Resources (https://www.locksleyresources.com.au) is an Australian-based explorer focused on critical minerals and base metals, with assets in both the U.S. and Australia. The company is actively advancing its U.S. asset, the Mojave Project, in California, targeting rare earth elements (REEs) and antimony. The company has also announced a strategic collaboration with Rice University to develop DeepSolv™, for domestic processing of North American antimony. The agreement is part of Locksley’s U.S. Critical Minerals and Energy Resilience Strategy to accelerate “mine-to-market” deployment of antimony in the U.S.

Contact: Beverly Jedynak, beverly.jedynak@viriathus.com, 312-943-1123; 773-350-5793 (cell)

SOPHiA GENETICS Expands Collaboration with AstraZeneca to Enhance Detection of Breast and Prostate Cancer

BOSTON, Sept. 22, 2025 /PRNewswire/ — SOPHiA GENETICS (Nasdaq: SOPH), an AI technology company transforming precision medicine, today announced an expansion of its collaboration with AstraZeneca (LSE/STO/Nasdaq: AZN) from the World CB & CDx Summit in Boston. The companies aim to improve the diagnosis and treatment of breast and prostate cancer by developing an optimized next generation sequencing (NGS) solution that leverages SOPHiA GENETICS’s AI algorithms to detect genetic mutations in the PIK3CA/AKT1/PTEN pathway.

The PIK3CA/AKT1/PTEN pathway is a key molecular signaling network that regulates how cells grow and survive, and its disruption is linked to the development of many cancers, including breast and prostate cancer. The PTEN gene, when altered, can contribute to cancer development and resistance to treatment. As part of this collaboration, the companies have developed an optimized NGS solution that deploys AI agents to analyze and detect genomic mutations across the full PTEN gene. A prototype of the enhanced solution has already demonstrated improved sensitivity in its ability to detect complex mutations across the pathway.

As part of the agreement, SOPHiA GENETICS will roll out a Privileged Access Program to selected clinical laboratories specializing in breast and prostate cancer research to validate sensitivity in a real-world setting, with broader commercial availability expected in 2026, alongside a multi-center real-world evidence study to further test its effectiveness. SOPHiA GENETICS’s global network will also help drive adoption of advanced PIK3CA/AKT1/PTEN testing in both tissue and liquid biopsy to expand patient access to precision therapies.

“Each day brings new insights that transform our understanding of cancer. Partnering with innovative biopharma leaders like AstraZeneca allows us to translate these discoveries into action for breast and prostate cancer patients worldwide, representing another step forward in our mission to democratize data-driven medicine.” said Ross Muken, President, SOPHiA GENETICS.

The expanded partnership highlights the shared commitment of SOPHiA GENETICS and AstraZeneca to drive innovation in precision oncology and to ensure that patients across the globe can benefit from advanced genomic testing and targeted treatments. To learn more, connect with SOPHiA GENETICS at the World CB & CDx Summit in Boston, MA from September 22-25, 2025.

For more information on SOPHiA GENETICS, visit SOPHiAGENETICS.COM, or connect on LinkedIn

About SOPHiA GENETICS  

SOPHiA GENETICS (Nasdaq: SOPH) is a cloud-native healthcare technology company on a mission to expand access to data-driven medicine by using AI to deliver world-class care to patients with cancer and rare disorders across the globe. It is the creator of the SOPHiA DDM™ Platform, which analyzes complex genomic and multimodal data and generates real-time, actionable insights for a broad global network of hospital, laboratory, and biopharma institutions.  For more information, visit SOPHiAGENETICS.COM and connect with us on LinkedIn

SOPHiA GENETICS products are for Research Use Only and not for use in diagnostic procedures unless specified otherwise. The information in this press release is about products that may or may not be available in different countries and, if applicable, may or may not have received approval or market clearance by a governmental regulatory body for different indications for use. Please contact support@sophiagenetics.com to obtain the appropriate product information for your country of residence. 

SOPHiA GENETICS Forward-Looking Statements:  
This press release contains statements that constitute forward-looking statements. All statements other than statements of historical facts contained in this press release, including statements regarding our future results of operations and financial position, business strategy, products, and technology, as well as plans and objectives of management for future operations, are forward-looking statements. Forward-looking statements are based on our management’s beliefs and assumptions and on information currently available to our management. Such statements are subject to risks and uncertainties, and actual results may differ materially from those expressed or implied in the forward-looking statements due to various factors, including those described in our filings with the U.S. Securities and Exchange Commission. No assurance can be given that such future results will be achieved. Such forward-looking statements contained in this press release speak only as of the date hereof. We expressly disclaim any obligation or undertaking to update these forward-looking statements contained in this press release to reflect any change in our expectations or any change in events, conditions, or circumstances on which such statements are based, unless required to do so by applicable law. No representations or warranties (expressed or implied) are made about the accuracy of any such forward-looking statements. 

Plume Appoints Former NASA Engineer, Startup CTO Mik Cox as Senior Vice President of Technology Innovation

Cox brings leadership experience in IoT, smart home, and AI-powered systems to help Plume define and deploy its next wave of market-defining technology for ISPs

PALO ALTO, Calif., Sept. 22, 2025 /PRNewswire/ — Plume today appointed former Ubiety Chief Technology Officer and NASA Jet Propulsion Laboratory (JPL) engineer Mik Cox as Senior Vice President of Technology Innovation. Cox will lead the company’s new technology innovation team, which will build upon Plume’s legacy of innovation and define and realize its next market-defining technology for customers. With almost half a billion devices connected to the Plume intelligent platform, Cox joins at a critical time when the company is shifting to a more open and collaborative approach in helping ISPs deliver smarter Wi-Fi experiences and building for the future.

Mik Cox joins Plume as Senior Vice President of Technology Innovation.
Mik Cox joins Plume as Senior Vice President of Technology Innovation.

Cox brings a track record of innovation and fresh perspective to Plume’s leadership team. Cox will work across product, engineering, sales, and data teams to translate frontier research into enterprise grade solutions for ISPs that move the conversation from raw speed to more reliable, proactive, and personalized Wi-Fi experiences in the home. From responsible AI adoption and self-healing home networks to the creation of a network intelligence operating system, Cox will play an important role in setting technology priorities for the company and deploying those at scale with Plume’s ecosystem partners and customers.

“Mik brings a mix of engineering chops, entrepreneurial spirit, and forward-looking thinking to this new role which will help create the roadmap for our next category-defining products for customers,” said Dan Herscovici, CEO of Plume. “Service providers are moving beyond speed to a world where personalized experiences and reliability will win the day. Mik will help to identify these opportunities with his team and align our product technology strategy accordingly. He and his team are already hard at work.”

Cox joins Plume from Ubiety, where he rose from founding engineer to CTO. He led the creation of Ubiety’s novel presence detection platform, the first AI system that determines presence using wireless signals emitted by electronic devices. At NASA’s JPL, Cox helped develop NASA’s first Alexa skill and led the popular Open Source Rover project. His team prototyped and delivered smart home and other connected technologies that improved the NASA campus by blending AI, data science, RFID systems, and other sensor networks.

“Plume has built an impressive foundation of technology capabilities and intelligent connectivity that defined a category,” says Cox. “I am eager to build on this innovative DNA by embarking on frontier R&D efforts and turning them into carrier-grade products. Plume is a company with the data, the partnerships, and I believe the vision to again define what next-generation network intelligence will be – and what it can unlock for service providers and their subscribers.”

Cox is the latest executive hire from Plume as it reshapes its executive team with an eye on better supporting its ISP partners, embracing open standards, and advancing innovations that power the future of connectivity in the home. These hires hail from a range of industries such as broadband, artificial intelligence, IoT, cybersecurity, and blockchain – each area playing an important role in this mission.

Plume is also excited to announce two additional team members who are joining the company and will be part of Plume’s engineering leadership team. Gavin Rawson has joined as Vice President, Engineering for the EU market, with previous experience at Bitdefender and CUJO AI. Sean Li joins as Vice President of Operations, following leadership roles at Klaviyo and Zscaler.

About Plume
Plume created the first managed Wi-Fi platform for Internet Service Providers (ISPs) in 2016 and continues to lead today with a best-in-class solution for cloud-managed Wi-Fi, security, and experience. With almost half a billion devices connected to its platform, Plume is a trusted technology partner for more than 400 ISPs around the world, helping them deliver better Wi-Fi experiences and services for subscribers while streamlining their own operations and support systems. Plume leverages OpenSync®, an open-source framework that comes pre-integrated and supported on the leading silicon, CPE, and platform SDKs, and supports leading industry standards like RDK-B and prplWave. This approach allows Plume to offer turnkey and modular solutions, giving ISPs ultimate flexibility, while enabling simpler and faster deployments. Plume is leading the way in providing ISPs an intelligence and innovation edge to stay competitive and adapt to the changing needs of subscribers and the market. Discover more about how Plume is empowering ISPs by visiting www.plume.com.

 

LakeShore Biopharma Announces Transition to OTC Market Following Nasdaq Delisting

BEIJING, Sept. 22, 2025 /PRNewswire/ — LakeShore Biopharma Co., Ltd (Nasdaq: LSB) (“LakeShore Biopharma” or the “Company”), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer, today announced that effective with the opening of business today, September 22, 2025, the Company’s ordinary shares and warrants have been suspended from trading on The Nasdaq Capital Market (“Nasdaq”).

On the same day, the Company’s ordinary shares and warrants are expected to commence trading on the OTC Pink Open Market (“OTC Market”) under the symbols “LSBCF” and “LSBWF”, respectively.

This action follows the receipt of a delisting determination letter from Nasdaq on September 11, 2025, as previously disclosed by the Company on September 12, 2025. Nasdaq’s determination was based on the Company’s non-compliance with the minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) and its ineligibility for a compliance period under Nasdaq Listing Rule 5810(c)(3)(A)(iv) due to a prior reverse stock split.

The transition to the OTC Market does not change the Company’s business operations. The Company remains a reporting company with the U.S. Securities and Exchange Commission and is committed to maintaining transparency with its shareholders and the public.

About LakeShore Biopharma

LakeShore Biopharma, previously known as YS Biopharma, is a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer. It has developed a proprietary PIKA® immunomodulating technology platform and a new generation of preventive and therapeutic biologics targeting Rabies, Hepatitis B, Influenza, and other virus infections. The Company operates in China, Singapore, and the Philippines, and is led by a management team that combines rich local expertise and global experience in the biopharmaceutical industry. For more information, please visit https://investors.lakeshorebio.com/.

Cautionary Statement Regarding Forward-Looking Statements

This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical or current fact included in this press release are forward-looking statements, including but not limited to statements regarding the Board’s evaluation of the Proposal Letter and the Proposed Transaction. Forward-looking statements may be identified by the use of words such as “estimate,” “plan,” “project,” “potential,” “forecast,” “intend,” “will,” “expect,” “anticipate,” “believe,” “goal,” “seek,” “target” or other similar expressions that predict or indicate future events or trends or that are not statements of historical matters. These statements are based on various assumptions, whether identified in this press release, and on the current expectations of LakeShore Biopharma’s management and are not predictions of actual performance.

LakeShore Biopharma cannot assure you the forward-looking statements in this press release will be accurate. These forward-looking statements are subject to a number of risks and uncertainties, including those included under the heading “Risk Factors” in the Company’s Annual Report on Form 20-F filed with the Securities and Exchange Commission, or SEC, and other risks described in documents subsequently filed by the Company from time to time with the SEC. There may be additional risks that LakeShore Biopharma does not presently know or that LakeShore Biopharma currently believes are immaterial that could also cause actual results to differ from those contained in the forward-looking statements. In light of the significant uncertainties in these forward-looking statements, nothing in this press release should be regarded as a representation by any person that the forward-looking statements set forth herein will be achieved or that any of the contemplated results of such forward-looking statements will be achieved. The forward-looking statements in this press release represent the views of LakeShore Biopharma as of the date of this press release. Subsequent events and developments may cause those views to change. However, while LakeShore Biopharma may update these forward-looking statements in the future, there is no current intention to do so, except to the extent required by applicable law. You should, therefore, not rely on these forward-looking statements as representing the views of LakeShore Biopharma as of any date subsequent to the date of this press release. Except as may be required by law, LakeShore Biopharma does not undertake any duty to update these forward-looking statements.

First Phosphate Closes Third Tranche of Oversubscribed Private Placement


THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR
DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES

Saguenay, Quebec – (Newsfile Corp. – September 22, 2025) – First Phosphate Corp. (CSE: PHOS) (OTCQB: FRSPF) (FSE: KD0) (“First Phosphate” or the “Company“) is pleased to announce that on, September 19, 2025, it closed the third tranche of its non-brokered private placement financing (the “Offering“), as further described in the Company’s news releases dated August 5, August 25 and September 15, 2025.

In aggregate under the three tranches of the Offering, the Company raised gross proceeds of $11.4 million through the issuance of 13,067,400 Flow-Through Shares for gross proceeds of $6.5 million, and through the issuance of 9,785,000 Hard Dollar Units for gross proceeds of $4.89 million.

Under the third tranche of the Offering, the Company raised a total of $4.7 million through the issuance of 3,168,400 Flow-Through Shares for gross proceeds of $1.58 million and 6,220,000 Hard Dollar Units, comprised of 6,220,000 Common Shares and 3,110,000 Warrants, for gross proceeds of $3.1 million.

Together with this Offering, the Company has raised to date a total of approximately $39.9 million in 9 management-led non-brokered private-placement financings since June 2022 of which approximately $19.6 million has been closed over the last 5 months. The Company is also pleased to have been able to count on the support of numerous long-only private family offices and institutional funds including AlphaNorth Asset Management.

“Thanks to the trust placed in us, First Phosphate is now well-capitalized and remains on track to deliver a completed feasibility study by the end of 2026, mining permits by mid 2027 and an operating igneous phosphate mine supported by existing definitive, bankable offtake agreements by mid 2029,” says CEO, John Passalacqua. “Our timelines are aggressive, and, so they should be: an integrated North American lithium iron phosphate (“LFP”) battery supply chain is a matter of national security to both the United States and Canada.”

The Company paid $35,600 in cash, and issued 151,520 Common Shares and 222,720 Compensation Warrants to finders in connection with the third tranche. In total, in connection with the Offering, the Company paid $96,800 in cash finder’s fees, issued 694,640 Common Shares and advisory shares at a price of $0.50 per common share, and issued 888,240 Compensation Warrants, exercisable at a price of $0.50 per common share of the Company, until December 31, 2025, subject to an Accelerated Expiry Date. All securities issued under the Offering are subject to a four-month and one day statutory hold period in accordance with applicable securities laws. The Company intends to use the proceeds from the Offering as disclosed in the Company’s press release dated August 5, 2025. Capitalized terms used in this news release and not defined herein have the meanings given to them in the Company’s news release dated August 5, 2025. The Company may close a final tranche of the Offering at its discretion on or before September 23, 2025.

The Company is also pleased to announce that it has entered into an advertising and e-marketing contract with NaFinance.com (the “Contractor”) to provide marketing services, including internet and social media engagement. The initial term of the agreement is for 13 months, commencing on September 22, 2025, and may be renewed with mutual written agreement. During the initial term the Contractor will be paid $2,800. The contractor is based at 22 Larksmere Court, Markham, Ontario L3R 3R1, and reachable at (416) 756-9328.

Insider Participation

In connection with the Offering, a company controlled by Larry Zeifman, Chairman of the Board of the Company, and a company controlled by Peter Nicholson, director of the Company, each purchased 280,112 Common Shares.

As related parties of the Company purchased Common Shares, the transactions are considered related party transactions for the purposes of Multilateral Instrument 61-101 – Protection of Minority Security Holders in Special Transactions (“MI 61-101”). The participation of the related parties of the Company are exempt from the formal valuation and minority shareholder approval requirements provided under MI 61-101 in accordance with sections 5.5(a) and 5.7(1)(a) of MI 61-101. The Company is relying on an exemption from the formal valuation requirements of MI 61-101 available because the fair market value of the Common Shares purchased by and issued to the related parties does not exceed 25% of the Company’s market capitalization, as determined in accordance with MI 61-101. The Company did not file a material change report related to the transactions more than 21 days before the expected closing of the transactions as required by MI 61-101 but believes that this shorter period is reasonable and necessary in the circumstances as the Company wishes to improve its financial position and to close the Offering in short order for sound business reasons.

This news release does not constitute an offer to sell or a solicitation of an offer to sell any of securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”) or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available. Completion of the Offering is subject to certain conditions including, but not limited to, the receipt of all necessary approvals. There can be no assurance that any further securities will be sold under Offering.

About First Phosphate Corp.

First Phosphate (CSE: PHOS) (OTCQB: FRSPF) (FSE: KD0) is a mineral development company dedicated to producing high-purity phosphate for the LFP battery industry. The Company is committed to sustainable extraction and purification with a low anticipated carbon footprint. Its vertically integrated model connects phosphate mining directly into the supply chains of North American battery producers. First Phosphate’s flagship project, the Bégin-Lamarche Property in Saguenay-Lac-Saint-Jean, Quebec, contains igneous anorthosite rock that yields high-purity phosphate with minimal impurities.

For additional information, please contact:

Bennett Kurtz
Chief Financial Officer
bennett@firstphosphate.com
Tel: +1 (416) 200-0657

Investor Relations: investor@firstphosphate.com
Media Relations: media@firstphosphate.com
Website: www.FirstPhosphate.com

Follow First Phosphate:

Twitter: https://twitter.com/FirstPhosphate
LinkedIn: https://www.linkedin.com/company/first-phosphate

Forward-Looking Information and Cautionary Statements
This news release contains certain statements and information that may be considered “forward-looking statements” and “forward-looking information” within the meaning of applicable securities laws. In some cases, but not necessarily in all cases, forward-looking statements and forward-looking information can be identified by the use of forward-looking terminology such as “plans”, “targets”, “expects” or “does not expect”, “is expected”, “an opportunity exists”, “is positioned”, “estimates”, “intends”, “assumes”, “anticipates” or “does not anticipate” or “believes”, or variations of such words and phrases or statements that certain actions, events or results “may”, “could”, “would”, “might”, “will” or “will be taken”, “occur” or “be achieved” and other similar expressions. In addition, statements in this news release that are not historical facts are forward-looking statements, including, among other things: the Company’s planned exploration and production activities; the properties and composition of any extracted phosphate; the investment strategy decisions of investors in the Company; the sufficiency of the capitalization of the Company; timelines for the completion of completion of the Company’s feasibility study, receipt of mining permits and an operating igneous phosphate mine; the Company’s plans for vertical integration into North American battery supply chains; and the receipt of all necessary approvals.

These statements and other forward-looking information are based on assumptions and estimates that the Company believes are appropriate and reasonable in the circumstances, which may prove to be incorrect, include, but are not limited to, the various assumptions set forth herein and in the Company’s public disclosure record including the short form base prospectus dated June 5, 2024, a well as, the receipt of all necessary approvals, including the there being no significant disruptions affecting the activities of the Company or inability to access required project inputs; permitting and development of the projects being consistent with the Company’s expectations; the accuracy of the current mineral resource estimates for the Company and results of metallurgical testing; certain price assumptions for P2O5 and Fe2O3; inflation and prices for Company project inputs being approximately consistent with anticipated levels; the Company’s relationship with First Nations and other Indigenous parties remaining consistent with the Company’s expectations; the Company’s relationship with other third party partners and suppliers remaining consistent with the Company’s expectations; and government relations and actions being consistent with Company expectations.

There can be no assurance that such statements will prove to be accurate, and actual results and future events could differ materially from those anticipated in such statements. There can be no assurance that any opportunity will be successful, commercially viable, completed on time or on budget, or will generate any meaningful revenues, savings or earnings, as the case may be, for the Company. In addition, the Company will incur costs in pursuing any particular opportunity, which may be significant. These factors and assumptions are not intended to represent a complete list of the factors and assumptions that could affect the Company and, though they should be considered carefully, should be considered in conjunction with the risk factors described in the Company’s other documents filed with the Canadian and United States securities authorities, including without limitation the “Risk Factors” section of the Company’s Management Discussion and Analysis dated January 29, 2025 and Annual Report on 20-F dated July 8, 2024, which are available on SEDAR at www.sedarplus.ca. Although the Company has attempted to identify factors that would cause actual actions, events or results to differ materially from those disclosed in the forward-looking information or information, there may be other factors that cause actions, events or results not to be as anticipated, estimated or intended. The Company does not undertake to update any forward-looking information, except in accordance with applicable securities laws.

The issuer is solely responsible for the content of this announcement.

About First Phosphate Corp.

Shenzhen leads digital energy development, the International Digital Energy Expo 2025 has opened

SHENZHEN, China, Sept. 22, 2025 /PRNewswire/ — The 2025 International Digital Energy Expo opened Sept. 18 at the Shenzhen Convention and Exhibition Center in Futian District, attracting more than 2,000 enterprises from over 50 countries. Focusing on the deep integration of digital technology and energy, the event has garnered strong interest from international participants, who see it as a window into the future of the energy sector. The exhibition showcased over 300 cutting-edge technologies from the entire energy supply chain, from power generation and grid networks to load management and storage.

Shenzhen leads digital energy development, the International Digital Energy Expo 2025 has opened
Shenzhen leads digital energy development, the International Digital Energy Expo 2025 has opened

A key moment of the opening ceremony was the release of the “2025 Shenzhen Digital Energy White Paper.” This document outlines a strategic implementation path for Shenzhen to establish itself as a global pioneer in digital energy. Its core strategy focuses on six areas: energy production, grid, load, storage, digitalization, and decarbonization.

The plan aims to create three flagship initiatives for the city: a next-generation “Supercharging City 2.0,” an integrated power charging-storage-discharge network, and a cloud-based virtual power plant management platform. The white paper details that these will be achieved by establishing four major centers, cultivating leading industrial companies ranking among the top 100, and developing 10 key solutions.

China has evolved from a “technology follower” to a “rule maker” in the digital energy sector, playing a pivotal role in reshaping global energy governance. This year’s expo, that closed on Sept. 21, featured dedicated zones for international exhibitors and business matchmaking, providing a platform for cooperation and exchange. The event has also attracted official delegations from Arab countries, Hungary, Italy, Portugal, and other countries, who shared their region’s energy transition experiences and investment opportunities.

The exhibition had a dedicated zone for electric heavy-duty trucks, with seven key enterprises, including BYD, Skyworth, Dongfeng, GAC, XCMG, Deepway, and Dawei Hongde, deploying nearly 10 electric heavy-duty trucks, fully demonstrating Shenzhen’s speed as a “Supercharging City 2.0”. BYD’s Haohan Energy Storage system made its global debut, boasting a minimum unit capacity of 14.5 MWh, setting a new world record. Huawei showcased its smart photovoltaic technology, smart charging network, and digital and intelligent power facility solution. CGN exhibited “Hualong One”, its third-generation million-kilowatt pressurized water reactor (PWR) technology. Sunwoda presented the industry’s first large-capacity supercharging cell specifically designed for heavy-duty trucks.

These groundbreaking practices demonstrate Shenzhen’s innovative strength in the digital energy field and provide replicable “Shenzhen solutions” for high-density cities worldwide to achieve their own energy transformation.